{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:28:55Z","timestamp":1769560135052,"version":"3.49.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi221319-4\"><jats:title>Importance<\/jats:title><jats:p>California\u2019s tobacco control efforts have been associated with a decrease in cancer mortality, but these estimates are based on smoking prevalence of the general population. Patient-level tobacco use information allows for more precise estimates of the proportion of cancer deaths attributable to smoking.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221319-5\"><jats:title>Objective<\/jats:title><jats:p>To calculate the proportion (smoking-attributable fraction) and number (smoking-attributable cancer mortality) of cancer deaths attributable to tobacco use using patient-level data.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221319-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>The smoking-attributable fraction and smoking-attributable cancer mortality were calculated for a retrospective cohort of patients whose cancer was diagnosed from 2014 to 2019 with at least 1 year of follow-up using relative risks from large US prospective studies and patient-level smoking information. Follow-up continued through April 2022. A population-based cohort was identified from the California Cancer Registry. Participants included adults aged 20 years and older with a diagnosis of 1 of the 12 tobacco-related cancers (oral cavity or pharynx, larynx, esophagus, lung, liver, stomach, pancreas, kidney, bladder, colon or rectum, cervix, and acute myeloid leukemia).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221319-7\"><jats:title>Exposures<\/jats:title><jats:p>Tobacco use defined as current, former, or never.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221319-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The primary outcomes were the smoking-attributable fraction and smoking-attributable cancer mortality for each of the 12 tobacco-related cancers over 2 time periods (2014-2016 vs 2017-2019) and by sex.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221319-9\"><jats:title>Results<\/jats:title><jats:p>Among 395\u202f459 patients with a tobacco-related cancer, most (285\u202f768 patients [72.3%]) were older than 60 years, the majority (228\u202f054 patients [57.7%]) were non-Hispanic White, 229\u202f188 patients were men (58.0%), and nearly one-half (184\u202f415 patients [46.6%]) had lung or colorectal cancers. Nearly one-half of the deaths (93\u202f764 patients [45.8%]) in the cohort were attributable to tobacco. More than one-half (227\u202f660 patients [57.6%]) of patients had ever used tobacco, and 69\u202f103 patients (17.5%) were current tobacco users, which was higher than the proportion in the general population (11.7%). The overall smoking-attributable fraction of cancer deaths decreased significantly from 47.7% (95% CI, 47.3%-48.0%) in 2014 to 2016 to 44.8% (95% CI, 44.5%-45.1%) in 2017 to 2019, and this decrease was seen for both men and women. The overall smoking-attributable cancer mortality decreased by 10.2%.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221319-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>California still has a substantial burden of tobacco use and associated cancer. The proportion of cancer deaths associated with tobacco use was almost double what was previously estimated. There was a modest but significant decline in this proportion for overall tobacco-associated cancers, especially for women.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.46651","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T16:01:06Z","timestamp":1671033666000},"page":"e2246651","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of Cancer Deaths Attributable to Tobacco in California, 2014-2019"],"prefix":"10.1001","volume":"5","author":[{"given":"Frances B.","family":"Maguire","sequence":"first","affiliation":[{"name":"California Cancer Reporting and Epidemiologic Surveillance Program, University of California Davis Comprehensive Cancer Center, Sacramento"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ani S.","family":"Movsisyan","sequence":"additional","affiliation":[{"name":"California Cancer Reporting and Epidemiologic Surveillance Program, University of California Davis Comprehensive Cancer Center, Sacramento"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyllene R.","family":"Morris","sequence":"additional","affiliation":[{"name":"California Cancer Reporting and Epidemiologic Surveillance Program, University of California Davis Comprehensive Cancer Center, Sacramento"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arti","family":"Parikh-Patel","sequence":"additional","affiliation":[{"name":"California Cancer Reporting and Epidemiologic Surveillance Program, University of California Davis Comprehensive Cancer Center, Sacramento"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa H. M.","family":"Keegan","sequence":"additional","affiliation":[{"name":"California Cancer Reporting and Epidemiologic Surveillance Program, University of California Davis Comprehensive Cancer Center, Sacramento"},{"name":"Center for Oncology Hematology Outcomes Research and Training, Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa K.","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of California Davis, Sacramento"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"issue":"24","key":"zoi221319r2","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1056\/NEJM200012143432406","article-title":"Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease.","volume":"343","author":"Fichtenberg","year":"2000","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi221319r3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1023\/B:CACO.0000036187.13805.30","article-title":"Association of the California tobacco control program with declines in lung cancer incidence.","volume":"15","author":"Barnoya","year":"2004","journal-title":"Cancer Causes Control"},{"issue":"5","key":"zoi221319r4","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/PHH.0000000000000780","article-title":"The impact of implementing tobacco control policies: the 2017 Tobacco Control Policy Scorecard.","volume":"24","author":"Levy","year":"2018","journal-title":"J Public Health Manag Pract"},{"key":"zoi221319r6","doi-asserted-by":"publisher","first-page":"i62","DOI":"10.1136\/tc.2009.030791","article-title":"Smoking-attributable cancer mortality in California, 1979-2005.","volume":"19","author":"Cowling","year":"2010","journal-title":"Tob Control"},{"issue":"1","key":"zoi221319r7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/1940-6207.CAPR-18-0341","article-title":"Trends in lung cancer and cigarette smoking: California compared to the rest of the United States.","volume":"12","author":"Pierce","year":"2019","journal-title":"Cancer Prev Res (Phila)"},{"issue":"12","key":"zoi221319r9","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1001\/jamainternmed.2016.6530","article-title":"State-level cancer mortality attributable to cigarette smoking in the United States.","volume":"176","author":"Lortet-Tieulent","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"9","key":"zoi221319r10","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1001\/jamainternmed.2015.2398","article-title":"Deaths due to cigarette smoking for 12 smoking-related cancers in the United States.","volume":"175","author":"Siegel","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"6","key":"zoi221319r12","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/EDE.0b013e3181577654","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"18","author":"von Elm","year":"2007","journal-title":"Epidemiology"},{"issue":"4","key":"zoi221319r14","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1177\/0962280214521348","article-title":"Multiple imputation of covariates by fully conditional specification: accommodating the substantive model.","volume":"24","author":"Bartlett","year":"2015","journal-title":"Stat Methods Med Res"},{"key":"zoi221319r15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2147\/CLEP","article-title":"Comorbidity index in central cancer registries: the value of hospital discharge data.","volume":"9","author":"Lichtensztajn","year":"2017","journal-title":"Clin Epidemiol"},{"issue":"3","key":"zoi221319r16","first-page":"505","article-title":"Why does adult African-American smoking prevalence in California remain higher than for non-Hispanic whites?","volume":"15","author":"Trinidad","year":"2005","journal-title":"Ethn Dis"},{"issue":"6","key":"zoi221319r17","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ntr\/ntu221","article-title":"Light and intermittent smoking among California Black, Hispanic\/Latino, and non-Hispanic White men and women.","volume":"17","author":"Pulvers","year":"2015","journal-title":"Nicotine Tob Res"},{"issue":"4","key":"zoi221319r18","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2307\/2529268","article-title":"The estimation and interpretation of attributable risk in health research.","volume":"32","author":"Walter","year":"1976","journal-title":"Biometrics"},{"issue":"7","key":"zoi221319r19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMsa1407211","article-title":"Smoking and mortality\u2014beyond established causes.","volume":"372","author":"Carter","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi221319r20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3322\/caac.21440","article-title":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States.","volume":"68","author":"Islami","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"zoi221319r23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257553","article-title":"Tobacco price and use following California Proposition 56 tobacco tax increase.","volume":"16","author":"Gunadi","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"zoi221319r25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.annepidem.2014.11.008","article-title":"What proportion of cancer deaths in the contemporary United States is attributable to cigarette smoking?","volume":"25","author":"Jacobs","year":"2015","journal-title":"Ann Epidemiol"},{"issue":"11","key":"zoi221319r26","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1007\/s11606-022-07542-0","article-title":"Assessment and counseling gaps among former smokers eligible for lung cancer screening in US adults: a cross-sectional analysis of National Health and Nutrition Examination Surveys (NHANES), 2013-2018.","volume":"37","author":"Hood-Medland","year":"2022","journal-title":"J Gen Intern Med"},{"issue":"5","key":"zoi221319r27","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/jamia\/ocac020","article-title":"Inaccuracies in electronic health records smoking data and a potential approach to address resulting underestimation in determining lung cancer screening eligibility.","volume":"29","author":"Kukhareva","year":"2022","journal-title":"J Am Med Inform Assoc"},{"issue":"11","key":"zoi221319r28","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1002\/cncr.29964","article-title":"Cognitive testing of tobacco use items for administration to patients with cancer and cancer survivors in clinical research.","volume":"122","author":"Land","year":"2016","journal-title":"Cancer"},{"issue":"6","key":"zoi221319r29","doi-asserted-by":"publisher","first-page":"S214","DOI":"10.1016\/j.amepre.2018.07.045","article-title":"Building and scaling-up California Quits: supporting health systems change for tobacco treatment.","volume":"55","author":"Kaslow","year":"2018","journal-title":"Am J Prev Med"},{"issue":"11","key":"zoi221319r31","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1158\/1940-6207.CAPR-19-0182","article-title":"Tobacco treatment program implementation at NCI cancer centers: progress of the NCI Cancer Moonshot-funded cancer center cessation initiative.","volume":"12","author":"D\u2019Angelo","year":"2019","journal-title":"Cancer Prev Res (Phila)"},{"key":"zoi221319r1","unstructured":"US Department of Health and Human Services. The health consequences of smoking\u201450 years of progress: a report of the Surgeon General. 2014. Accessed April 12, 2022. https:\/\/www.hhs.gov\/surgeongeneral\/reports-and-publications\/tobacco\/index.html"},{"key":"zoi221319r5","unstructured":"Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, BRFSS. Current cigarette use among adults. 2019. Accessed January 26, 2022. https:\/\/www.cdc.gov\/statesystem\/cigaretteuseadult.html"},{"key":"zoi221319r8","unstructured":"UCLA Center for Health Policy Research. Ask CHIS 2016-2018. Current smoking status. Accessed January 27, 2022. https:\/\/ask.chis.ucla.edu\/"},{"key":"zoi221319r11","unstructured":"National Cancer Institute Surveillance Epidemiology and End Results Program. Site recode ICD-O-3\/WHO 2008 definition. 2008. Accessed August 31, 2022. https:\/\/seer.cancer.gov\/siterecode\/icdo3_dwhoheme\/"},{"key":"zoi221319r13","unstructured":"California Department of Public Health, Comprehensive Cancer Control Program. Tobacco cessation in cancer prevention and treatment: a call to action for California cancer centers. University of California, Davis, and California Dialogue on Cancer (CDOC) Tobacco Stakeholder Advisory Group. April 2015. Accessed June 22, 2022. https:\/\/www.cdph.ca.gov\/Programs\/CCDPHP\/DCDIC\/CDSRB\/CDPH%20Document%20Library\/CDOC\/TobaccoCessation_CallToAction-ADA.pdf"},{"key":"zoi221319r21","unstructured":"Centers for Disease Control and Prevention. Smoking-attributable mortality, morbidity, and economic costs, Cancer Prevention Study II. Accessed October 13, 2022. https:\/\/academic.oup.com\/view-large\/19992493"},{"key":"zoi221319r22","unstructured":"California Cancer Registry, California Department of Public Health, CAL Explorer Application. Trends in incidence and mortality rates, 2000-2018. 2021. Accessed January 26, 2022. https:\/\/explorer.ccrcal.org\/index.html"},{"key":"zoi221319r24","unstructured":"US Department of Health and Human Services. Smoking cessation: a report of the Surgeon General. 2020. Accessed April 13, 2022. https:\/\/www.hhs.gov\/sites\/default\/files\/2020-cessation-sgr-full-report.pdf"},{"key":"zoi221319r30","unstructured":"Commission on Cancer, American College of Surgeons. Just ASK quality improvement project and clinical study. 2022. Accessed October 21, 2022. https:\/\/www.facs.org\/quality-programs\/cancer-programs\/pdsa-just-ask\/"},{"key":"zoi221319r32","unstructured":"US Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. 2006. Accessed November 4, 2022. https:\/\/dbh.dc.gov\/sites\/default\/files\/dc\/sites\/doh\/publication\/attachments\/Executive_Summary_2nd_Hand_Smoke_SG_Report_2006.pdf"},{"key":"zoi221319r33","unstructured":"National Toxicology Program. Tobacco-related exposures: report on carcinogens. Fourteenth edition. 2016. https:\/\/ntp.niehs.nih.gov\/whatwestudy\/assessments\/cancer\/roc\/index.html"},{"key":"zoi221319r34","unstructured":"US Environmental Protection Agency. Respiratory health effects of passive smoking: lung cancer and other disorders. 1992. Accessed November 4, 2022. https:\/\/www.epa.gov\/indoor-air-quality-iaq\/respiratory-health-effects-passive-smoking-lung-cancer-and-other-disorders"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2799551\/maguire_2022_oi_221319_1670430042.37321.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T16:01:20Z","timestamp":1671033680000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2799551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.46651","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,14]]}}}